Bausch & Lomb Incorporated

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1992-10-08

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of Clinical Outcomes Following Implantation of a Sub-2mm Hydrophilic MICS Intraocular Lens

Not Applicable

Completed

Conditions: Cataract

Interventions: Device: IOL Implantation

First Posted Date: 2012-06-11

Last Posted Date: 2019-11-14

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 103

Registration Number: NCT01615861

Locations: 🇫🇷
Bausch & Lomb, Labege, France

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Phase 3

Completed

Conditions: Surgery
Inflammation
Cataract

Interventions: Drug: Vehicle
Drug: Mapracorat

First Posted Date: 2012-05-04

Last Posted Date: 2020-09-03

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 360

Registration Number: NCT01591655

Locations: 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Phase 3

Completed

Conditions: Cataract
Inflammation
Surgery

Interventions: Drug: Placebo
Drug: Mapracorat

First Posted Date: 2012-05-03

Last Posted Date: 2020-09-03

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 369

Registration Number: NCT01591161

Locations: 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States

A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: PureVision2
Device: B&L RD2135-01 lens C
Device: Air Optix Aqua
Device: B&L RD2135-01 lens D

First Posted Date: 2012-04-24

Last Posted Date: 2020-10-22

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 216

Registration Number: NCT01583868

Locations: 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States

Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis

Phase 2

Completed

Conditions: Seasonal Allergic Rhinitis

Interventions: Drug: Bepotastine besilate formulation
Drug: Fluticasone propionate
Drug: Bepotastine besilate-fluticasone propionate
Drug: Placebo Comparator

First Posted Date: 2012-04-16

Last Posted Date: 2020-10-05

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 606

Registration Number: NCT01578278

Locations: 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States

Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium

Phase 4

Completed

Conditions: Age-Related Macular Degeneration
Retinal Vein Occlusion
Diabetic Macular Edema

Interventions: Drug: pegaptanib sodium injection

First Posted Date: 2012-04-09

Last Posted Date: 2021-01-08

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 131

Registration Number: NCT01573572

Locations: 🇺🇸
Wolfe Eye Clinic, Marshalltown, Iowa, United States
🇺🇸
Valley Retina Institute, Harlingen, Texas, United States
🇺🇸
Marietta Eye Clinic, Murrieta, California, United States

and more 1 locations

A Study to Evaluate the Product Performance of a Low Add MultiFocal Soft Contact Lens

Not Applicable

Completed

Conditions: Presbyopia

Interventions: Device: PureVision multifocal contact lens
Device: LD118033 contact lens

First Posted Date: 2012-02-27

Last Posted Date: 2020-09-30

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 126

Registration Number: NCT01539694

Locations: 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States

A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens

Not Applicable

Completed

Conditions: Presbyopia

Interventions: Device: Investigational contact lens
Device: PureVision contact lens

First Posted Date: 2012-01-26

Last Posted Date: 2020-09-30

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 126

Registration Number: NCT01518868

Locations: 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States

Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.

Phase 3

Completed

Conditions: Cataract

Interventions: Drug: Prednisolones acetate
Drug: Loteprednol etabonate

First Posted Date: 2011-11-21

Last Posted Date: 2019-06-11

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 107

Registration Number: NCT01475643

Locations: 🇺🇸
Bausch & Lomb Inc, Rochester, New York, United States

A Study to Evaluate the Safety and Efficacy of a New Silicone Hydrogel Contact Lens Design

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: B&L Investigational Contact Lens
Device: B&L PureVision Contact Lens

First Posted Date: 2011-10-10

Last Posted Date: 2015-02-18

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 166

Registration Number: NCT01449526

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy